HCPCS code J3110: Teriparatide injection billing guide
HCPCS code J3110 is the Level II HCPCS code for injection of teriparatide, 10 mc...
Last Updated: Sep 7, 2026
Key takeaways
HCPCS code J2650 is the Level II J-code for injection of prednisolone acetate, up to 1 ml.
One unit equals 1 ml or less of drug administered, so units follow the dose and never the vial size.
Medicare prices J2650 under the Average Sales Price method, and CMS updates that rate every quarter.
Every Part B drug claim for J2650 needs the 11-digit NDC of the vial used, plus a paired ICD-10-CM diagnosis.
Practice management software like Pabau pre-fills claim forms, provides HCPCS and ICD-10 lookup libraries, and checks required fields before submission.
HCPCS code J2650 covers the injection of prednisolone acetate, up to 1 ml. It sits in Level II as a J-code, so it bills the drug itself rather than the procedure that delivered it. One unit means 1 ml or less of administered suspension.
Two entries on the claim line decide whether it pays. The first is the National Drug Code, or NDC, taken from the vial you used. The second is the diagnosis you pair with it. Miss either one and the payer rejects the drug line, even when the rest of the visit is clean.
What follows covers the descriptor, how Medicare prices the code, the NDC and unit rules, the diagnoses payers accept, and the documentation that supports them.
Found our content helpful?
What J2650 covers, and what it does not
J2650 identifies a single injectable drug for outpatient billing. It does not describe the injection procedure, the anatomical site, or the visit itself.
CMS maintains it under the Healthcare Common Procedure Coding System (HCPCS), in Level II. That level holds the HCPCS Level II codes for drugs, supplies, and services CPT leaves out.
Under the CMS HCPCS coding system, J-codes cover drugs a patient cannot self-administer. Most are given in a physician’s office or an outpatient setting. J2650 belongs to the corticosteroid injectables group, one of the most frequently billed drug categories in outpatient medicine.
Where prednisolone acetate injections are used
Prednisolone acetate is a synthetic corticosteroid with strong anti-inflammatory and immunosuppressive effects. Its suspension formulation suits local injection, where oral dosing would either work less well or carry more side effects.
Clinicians reach for it in four settings, and each one makes its own demands on the note:
- Ophthalmic: Uveitis, allergic conjunctivitis, and other inflammatory eye conditions. This is one of the most common uses billed under J2650.
- Intra-articular: Joint injections for osteoarthritis, rheumatoid arthritis, and acute inflammatory flares. Name the joint and the side in the note.
- Soft tissue: Injections into bursae, tendon sheaths, or trigger points for localized inflammation.
- Dermatological: Intralesional injection for hypertrophic scars, lichen planus, and other stubborn localized skin conditions.
Because the descriptor stops at 1 ml, one unit stands for a single injection episode of 1 ml or less. Administer more than that and you need to check whether extra units apply, or whether another code fits better. Either way, record the exact volume.
Medicare prices this code on ASP, and it moves quarterly
Medicare pays J2650 under the Average Sales Price (ASP) method, which CMS refreshes every quarter. The rate is usually ASP plus a percentage add-on, historically ASP+6% outside sequestration periods.
Because that figure moves four times a year, the table below describes the payment structure rather than a current dollar amount. Always verify the live rate in the CMS fee schedule lookup before you submit.
After each submission, read the electronic remittance advice (ERA) against the rate you expected. A payment below the current ASP figure points to one of two problems. Either the units on the line were wrong, or the payer applied a contractual adjustment worth chasing.
The NDC is what makes the drug line payable
Medicare wants the National Drug Code of the product administered on every Part B drug claim. The NDC-to-HCPCS crosswalk maps a manufacturer’s 11-digit NDC to the J-code, then converts units between the two systems. Without the right NDC, the claim gets denied outright.
Prednisolone acetate reaches the market from several manufacturers, so NDCs vary by supplier and package size. The table below breaks down the structure rather than listing specific numbers.
Check the active NDC against the current CMS NDC-to-HCPCS crosswalk file before you submit, because manufacturer updates change these numbers without notice.
Report the NDC in 11-digit 5-4-2 format, and match the unit of measure to the crosswalk file. A unit mismatch is one of the most common reasons a J-code drug claim gets flagged or denied. Either the AAPC HCPCS code lookup or the CMS crosswalk file will settle it before the claim leaves.
Which ICD-10 diagnoses support the injection
Medical necessity for a prednisolone acetate injection rests on a documented diagnosis. The paired ICD-10-CM code tells the payer why the injection was needed.
Local and national coverage determinations set out which diagnoses qualify, so treat the list below as commonly paired rather than guaranteed.
Reach for the most specific code the documentation supports. Unspecified-site codes such as M19.90 and M06.00 are acceptable when the note genuinely does not name a joint.
Payers still flag them for review more often. A site-specific alternative, say M19.011 for primary osteoarthritis of the right shoulder, draws fewer documentation requests.
Pro Tip
Audit the diagnosis before every J2650 claim goes out. The code has to match the injection site. It also has to appear on the payer’s active covered-diagnoses list. Finally, the note must tie that diagnosis to the reason for the injection. Those three passes catch most preventable J-code denials.
What the chart note has to prove
A clean J2650 claim depends on data captured at the time of service, not reconstructed later. Billing staff need the drug details before the claim is built. Clinicians need to write them down while the patient is still in the room.
Every J2650 claim rests on the documentation below:
- Drug name and dosage: Name prednisolone acetate, its concentration, and the volume given. For example, 40 mg/ml, 1 ml injected into the right knee.
- NDC number: Copy the NDC from the vial or package used. It goes on the claim form and has to match the CMS crosswalk file.
- Injection site: State the anatomical site. Name the joint and the side for intra-articular work, or the eye for ophthalmic work.
- Medical necessity: Explain why this patient needed the injection. A diagnosis on its own is not enough, so connect it to the treatment decision.
- Units of service: One unit covers up to 1 ml. Document each injection separately when several are given, and check the payer’s rules on multiple units per visit.
- Place of service: POS 11 for the office is the usual choice. POS 22 and POS 19 shift the claim onto facility rates.
Capturing the NDC and the diagnosis before the patient leaves prevents most J-code billing errors. Teams that pull charts retroactively to find NDC data generate far more rework than teams that capture it at checkout.
Quarterly self-audits close the loop. Pull a sample of J2650 submissions and check three points. NDC numbers should match the products on the shelf, units should reconcile with purchase records, and diagnoses should match the documented findings.
How the claim moves, and where it stalls
The J2650 line travels through five checkpoints, and it can fail at any of them. A later step never repairs an earlier mistake, so the order matters. Here is where each checkpoint sits, and what tends to break it.
Run that same order as a pre-submission checklist. Two minutes per claim beats a 30-day denial cycle.
- Volume administered and the injection site both appear in the note, with laterality where it applies.
- The 11-digit NDC on the claim matches the vial used, not a similar product from another manufacturer.
- Units reflect the dose given, so 1 ml administered means one unit of J2650.
- The ICD-10-CM code is as specific as the note allows, and it sits on the payer’s covered list.
- The expected payment in your system reflects the current quarter’s ASP file.
Of those five, unit conversion trips teams up most often. A 5 ml vial does not mean five units when only 1 ml went into the patient. Bill the dose, and remember that discarded volume from a multi-dose vial is not separately payable.
Corticosteroid J-codes that get confused with J2650
Prednisolone acetate is one of several corticosteroids with its own J-code. Picking the wrong one is both a billing error and a compliance problem. Unit bases differ as well, which is where most of the confusion starts. The comparison below lines up what one unit covers in each code.
Billing J3490 for prednisolone acetate is a common slip, and J2650 is the code that belongs on the line. J3490 triggers manual review at most payers and delays payment for weeks. Triamcinolone hits the same trap from the other direction. It needs J3301, and its per-10-mg unit does not translate to a per-ml unit.
What changed in the 2025 and 2026 HCPCS updates
J2650 has held the same descriptor through both cycles. CMS confirmed the code as valid for 2026, with no structural change to its short or long descriptor.
The code is stable, but its ASP rate is not. CMS releases updated ASP files in January, April, July, and October. Load each one into your charge capture data when it lands, because stale fee schedule figures quietly leak revenue on drug claims.
Pro Tip
Put a quarterly reminder in the billing calendar for the day the CMS ASP file drops. Update the expected payment for J2650 in your practice management system that same week. That one habit stops fee schedule drift, which is how underpayments sit unnoticed for months.
How Pabau helps billing teams submit J-code claims
Manual J-code billing spreads one claim across several places. The NDC sits on a vial in the treatment room. The unit conversion lives in a CMS spreadsheet.
Meanwhile, the ASP rate changes every 90 days. Each handoff is somewhere the drug line can go wrong.
Practice management software like Pabau keeps those pieces on one record. The code attached to the service lands on the charge line, and ICD-10 slots draw from the patient’s recorded problem list. Search icons open full ICD-10-CM and HCPCS lookup libraries, refreshed with each official release.
Pabau also checks that claim-required fields are complete before the send button unlocks, membership and authorization numbers included. Submission then runs through a regional clearinghouse, Claim.MD in the US, which returns eligibility checks, claim status, and ERA remittance posting.
These claims tools are built for billing teams working inside the clinical record rather than beside it. So there is no export step between the note and the claim, and nobody retypes an NDC from a vial label.
Keep J-code claims moving without the spreadsheets
Pabau pre-fills claim forms from the patient record and opens HCPCS and ICD-10 lookup libraries where your coders work. It also checks required fields before submission, then sends the claim through a regional clearinghouse. See how that handles corticosteroid injection billing.
Conclusion
J2650 is a simple descriptor with demanding paperwork behind it. The drug is easy to identify. Payment turns on three smaller details. The NDC has to be on the line, and the units have to match the dose. Beyond that, the diagnosis has to be specific enough to survive review.
So build the checks into the visit rather than the appeal. Capture the NDC at the point of care, load each quarterly ASP file the week it lands, and audit a sample of claims every quarter. Practices that do all three spend their time on patients instead of resubmissions.
Want to see how pre-filled claim forms, code lookup libraries, and required-field checks fit a corticosteroid injection workflow? Book a demo and we will walk through it against your own billing setup.
Continue your research
No specific J-code for the drug you gave? HCPCS code J3490 explains how the unclassified drug code works and what payers ask for.
Billing dexamethasone instead? HCPCS code J1100 covers dexamethasone sodium phosphate and its per-milligram unit.
Need a framework for cleaner submissions? Clean claim fundamentals covers the data elements every Part B drug claim needs to clear the first edit.
Chasing denials on drug lines? Denial management in healthcare sets out how to bring a HCPCS denial rate down.
New to the wider billing workflow? What is medical billing shows where drug claims sit in the revenue cycle.
Frequently asked questions
Can you bill J2650 and the injection procedure together?
Yes. J2650 pays for the drug, and a separate CPT code pays for administering it, such as 20610 for a major joint. Report both lines on the same claim and link them to the same diagnosis. Check the payer’s bundling rules first, because a few contracts fold the two together.
Does a J2650 line need a JW or JZ modifier?
Only when the drug comes from a single-dose container. CMS built JW and JZ for single-dose packaging, so a multi-dose prednisolone acetate vial takes neither. Read the label before you decide, since packaging differs by manufacturer.
Does Part B or Part D cover J2650?
Part B. A clinician administers the injection in the office, which keeps it outside the self-administered drugs Part D covers. Bill it on the professional claim, with the NDC attached to the drug line.
How long do you have to file a J2650 claim with Medicare?
One calendar year from the date of service. Medicare rejects claims filed after that, and a refile following a denial still counts inside the window. Commercial payers usually allow less, and 90 days is common, so check each contract.
Do commercial payers require prior authorization for prednisolone acetate injections?
Some do, mostly for repeat injections or ophthalmic use. Prior authorization depends on the plan rather than the code, so check the member’s policy before scheduling. A retroactive authorization request after the injection rarely succeeds.
Found our content helpful?
